Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition

Abstract: Oncogenic mutations in RAS family genes arise frequently in metastatic human cancers. Here we developed new mouse and cellular models of oncogenic HrasG12V-driven undifferentiated pleomorphic sarcoma metastasis and of KrasG12D-driven pancreatic ductal adenocarcinoma metastasis. Through analyses of these cells and of human oncogenic KRAS-, NRAS- and BRAF-driven cancer cell lines we identified that resistance to single MEK inhibitor and ERK inhibitor treatments arise rapidly but combination therapy completely blocks the emergence of resistance. The prior evolution of resistance to either single agent frequently leads to resistance to dual treatment. Dual MEK inhibitor plus ERK inhibitor therapy shows anti-tumor efficacy in an HrasG12V-driven autochthonous sarcoma model but features of drug resistance in vivo were also evident. Array-based kinome activity profiling revealed an absence of common patterns of signaling rewiring in single or double MEK and ERK inhibitor resistant cells, showing that the development of resistance to downstream signaling inhibition in oncogenic RAS-driven tumors represents a heterogeneous process. Nonetheless, in some single and double MEK and ERK inhibitor resistant cell lines we identified newly acquired drug sensitivities. These may represent additional therapeutic targets in oncogenic RAS-driven tumors and provide general proof-of-principle that therapeutic vulnerabilities of drug resistant cells can be identified

Angaben zum Objekt

• Standort: Deutsche Nationalbibliothek Frankfurt am Main
• Umfang: Online-Ressource
• Sprache: Englisch
• Anmerkungen: Cancers. - 13, 8 (2021) , 1852, ISSN: 2072-6694

Beteiligte, Orts- und Zeitangaben

• Ereignis: Veröffentlichung
• (wo): Freiburg
• (wer): Universität
• (wann): 2021
• Urheber: Catalano, Antonella ; Adlesic, Mojca ; Kaltenbacher, Thorsten ; Klar, Rhena F. U. ; Albers, Joachim ; Seidel, Philipp ; Brandt, Laura P. ; Hejhal, Tomas ; Busenhart, Philipp ; Röhner, Niklas ; Zodel, Kyra ; Fritsch, Kornelia ; Wild, Peter Johannes ; Duyster, Justus ; Fritsch, Ralph ; Brummer, Tilman ; Frew, Ian

Weitere Informationen

• DOI: 10.3390/cancers13081852
• URN: urn:nbn:de:bsz:25-freidok-1949089
• Rechteinformation: Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Letzte Aktualisierung: 14.08.2025, 11:02 MESZ